WHO ICTRP trial

A study to assess the effect Of the drug Tranexamic acid in reducing bloos loss…

CTRI/2017/09/009629 · Clinical Trials Registry India (CTRI) · Recruiting

Key facts

Trial ID CTRI/2017/09/009629
Public title A study to assess the effect Of the drug Tranexamic acid in reducing bloos loss during early excision of burn wound.
Scientific title Effect Of Single Intravenous Tranexamic acid On Blood Loss During Tangential Excision Of Burn Wound.
Primary sponsor Dept Of Plastic Surgery
Registry Clinical Trials Registry India (CTRI)
Recruitment status Recruiting
Study type Interventional
Phase Phase 4
Countries India
Conditions Health Condition 1: null- Those Who Sustained Less Than 40% Burns And Hemodynamically Stable
Interventions Intervention1: Tangential Excision Of Burn Wound: Early excision of the burn wound will be done by Tangentia excison. Control Intervention1: TRANEXAMIC ACID: During Tangential Excision Of Burn Wound single dose of I.V TRANEXAMIC ACID Will…
Registration date May 9, 2017
Target size 30
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations